Health-related quality of life in children with sickle cell disease: A report from the comprehensive sickle cell centers clinical trial consortium

Carlton Dampier, Susan Lieff, Petra LeBeau, Seungshin Rhee, Marsha McMurray, Zora Rogers, Kim Smith-Whitley, Winfred Wang

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Background. Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium to perform a detailed, descriptive study of HRQOL using the PedsQL™ version 4.0 generic core and fatigue scales. Methods. Retrospective clinical data were obtained via medical record abstraction. Staff-administered health history, psychosocial, and health behavior interviews were completed by a parent or guardian. PedsQL™ forms were completed separately by the child and a parent/guardian. Results. The study enrolled 1,772 subjects (53% boys) with a mean age of 9.6 years (SD 4.7). SS or Sβ0 thalassemia occurred in 68% and 32% had SC or Sβ+ thalassemia. The occurrences of pain, priapism, avascular necrosis of hips/shoulders (AVN), or asthma were the most common complications/conditions reported. Multiple regression models controlling for hemoglobinopathies, gender, and age suggested that parent reports of physical functioning and sleep/rest fatigue declined in response to pain or AVN, while school functioning scales declined in response to pain or asthma. Sickle pain, and to a lesser extent asthma, negatively influenced child reports on almost all functioning and fatigue scales. Conclusions. While longitudinal studies will be necessary to determine sensitivity to change, the current study suggests the potential utility of several PedsQL™ HRQOL scales as patient-reported outcome measures for observational or interventional treatment studies of children and adolescents with SCD.

Original languageEnglish (US)
Pages (from-to)485-494
Number of pages10
JournalPediatric Blood and Cancer
Volume55
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Sickle Cell Anemia
Quality of Life
Clinical Trials
Fatigue
Pain
Thalassemia
Asthma
Priapism
Hemoglobinopathies
Health Behavior
Sample Size
Medical Records
Longitudinal Studies
Hip
Sleep
Necrosis
Interviews
Pediatrics
Health
Therapeutics

Keywords

  • HRQOL
  • Peds QL
  • Sickle cell disease

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Medicine(all)

Cite this

Health-related quality of life in children with sickle cell disease : A report from the comprehensive sickle cell centers clinical trial consortium. / Dampier, Carlton; Lieff, Susan; LeBeau, Petra; Rhee, Seungshin; McMurray, Marsha; Rogers, Zora; Smith-Whitley, Kim; Wang, Winfred.

In: Pediatric Blood and Cancer, Vol. 55, No. 3, 09.2010, p. 485-494.

Research output: Contribution to journalArticle

Dampier, Carlton ; Lieff, Susan ; LeBeau, Petra ; Rhee, Seungshin ; McMurray, Marsha ; Rogers, Zora ; Smith-Whitley, Kim ; Wang, Winfred. / Health-related quality of life in children with sickle cell disease : A report from the comprehensive sickle cell centers clinical trial consortium. In: Pediatric Blood and Cancer. 2010 ; Vol. 55, No. 3. pp. 485-494.
@article{7c1be812873f4cdba672685efd8d7145,
title = "Health-related quality of life in children with sickle cell disease: A report from the comprehensive sickle cell centers clinical trial consortium",
abstract = "Background. Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium to perform a detailed, descriptive study of HRQOL using the PedsQL™ version 4.0 generic core and fatigue scales. Methods. Retrospective clinical data were obtained via medical record abstraction. Staff-administered health history, psychosocial, and health behavior interviews were completed by a parent or guardian. PedsQL™ forms were completed separately by the child and a parent/guardian. Results. The study enrolled 1,772 subjects (53{\%} boys) with a mean age of 9.6 years (SD 4.7). SS or Sβ0 thalassemia occurred in 68{\%} and 32{\%} had SC or Sβ+ thalassemia. The occurrences of pain, priapism, avascular necrosis of hips/shoulders (AVN), or asthma were the most common complications/conditions reported. Multiple regression models controlling for hemoglobinopathies, gender, and age suggested that parent reports of physical functioning and sleep/rest fatigue declined in response to pain or AVN, while school functioning scales declined in response to pain or asthma. Sickle pain, and to a lesser extent asthma, negatively influenced child reports on almost all functioning and fatigue scales. Conclusions. While longitudinal studies will be necessary to determine sensitivity to change, the current study suggests the potential utility of several PedsQL™ HRQOL scales as patient-reported outcome measures for observational or interventional treatment studies of children and adolescents with SCD.",
keywords = "HRQOL, Peds QL, Sickle cell disease",
author = "Carlton Dampier and Susan Lieff and Petra LeBeau and Seungshin Rhee and Marsha McMurray and Zora Rogers and Kim Smith-Whitley and Winfred Wang",
year = "2010",
month = "9",
doi = "10.1002/pbc.22497",
language = "English (US)",
volume = "55",
pages = "485--494",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Health-related quality of life in children with sickle cell disease

T2 - A report from the comprehensive sickle cell centers clinical trial consortium

AU - Dampier, Carlton

AU - Lieff, Susan

AU - LeBeau, Petra

AU - Rhee, Seungshin

AU - McMurray, Marsha

AU - Rogers, Zora

AU - Smith-Whitley, Kim

AU - Wang, Winfred

PY - 2010/9

Y1 - 2010/9

N2 - Background. Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium to perform a detailed, descriptive study of HRQOL using the PedsQL™ version 4.0 generic core and fatigue scales. Methods. Retrospective clinical data were obtained via medical record abstraction. Staff-administered health history, psychosocial, and health behavior interviews were completed by a parent or guardian. PedsQL™ forms were completed separately by the child and a parent/guardian. Results. The study enrolled 1,772 subjects (53% boys) with a mean age of 9.6 years (SD 4.7). SS or Sβ0 thalassemia occurred in 68% and 32% had SC or Sβ+ thalassemia. The occurrences of pain, priapism, avascular necrosis of hips/shoulders (AVN), or asthma were the most common complications/conditions reported. Multiple regression models controlling for hemoglobinopathies, gender, and age suggested that parent reports of physical functioning and sleep/rest fatigue declined in response to pain or AVN, while school functioning scales declined in response to pain or asthma. Sickle pain, and to a lesser extent asthma, negatively influenced child reports on almost all functioning and fatigue scales. Conclusions. While longitudinal studies will be necessary to determine sensitivity to change, the current study suggests the potential utility of several PedsQL™ HRQOL scales as patient-reported outcome measures for observational or interventional treatment studies of children and adolescents with SCD.

AB - Background. Pediatric health-related quality of life (HRQOL) questionnaires have been validated in children with sickle cell disease (SCD), but small sample sizes in these studies have limited clinical comparisons. We used the baseline clinical data from the Collaborative Data (C-Data) Project of the Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium to perform a detailed, descriptive study of HRQOL using the PedsQL™ version 4.0 generic core and fatigue scales. Methods. Retrospective clinical data were obtained via medical record abstraction. Staff-administered health history, psychosocial, and health behavior interviews were completed by a parent or guardian. PedsQL™ forms were completed separately by the child and a parent/guardian. Results. The study enrolled 1,772 subjects (53% boys) with a mean age of 9.6 years (SD 4.7). SS or Sβ0 thalassemia occurred in 68% and 32% had SC or Sβ+ thalassemia. The occurrences of pain, priapism, avascular necrosis of hips/shoulders (AVN), or asthma were the most common complications/conditions reported. Multiple regression models controlling for hemoglobinopathies, gender, and age suggested that parent reports of physical functioning and sleep/rest fatigue declined in response to pain or AVN, while school functioning scales declined in response to pain or asthma. Sickle pain, and to a lesser extent asthma, negatively influenced child reports on almost all functioning and fatigue scales. Conclusions. While longitudinal studies will be necessary to determine sensitivity to change, the current study suggests the potential utility of several PedsQL™ HRQOL scales as patient-reported outcome measures for observational or interventional treatment studies of children and adolescents with SCD.

KW - HRQOL

KW - Peds QL

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=77955486134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955486134&partnerID=8YFLogxK

U2 - 10.1002/pbc.22497

DO - 10.1002/pbc.22497

M3 - Article

C2 - 20658620

AN - SCOPUS:77955486134

VL - 55

SP - 485

EP - 494

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -